Celgene-CELG Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celgene-CELG

CELG 108.24

0.0%

Nov 22 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Bloxom who wrote (260)	2/10/1999 11:50:00 AM
From: Biomaven	Read Replies (1) of 804

John, The NY Times today quoted BMY as saying the problem was largely production, and implied efficacy was inconsistent. Sounded like they believed the molecule worked, but was currently impractical. I lightened up my MOGN holding this morning and switched the proceeds into increasing my CELG position. I'm assuming Thalomid sales will still be pretty small, but I'm prepared to look further than the current quarter. Only issue for me was whether to wait for their results in case I could pick it up cheaper then. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next